也是这时候,大概是2015年10月的时候吧,我开始觉得自己非常不


A revision of the 2008 British Association for Psychopharmacology evidence-based guidelines for treating depressive disorders with antidepressants was undertaken in order to incorporate new evidence and to update the recommendations where appropriate. A consensus meeting involving experts in depressive disorders and their management was held in September 2012. Key areas in treating depression were reviewed and the strength of evidence and clinical implications were considered. The guidelines were then revised after extensive feedback from participants and interested parties. A literature review is provided which identifies the quality of evidence upon which the recommendations are made. These guidelines cover the nature and detection of depressive disorders, acute treatment with antidepressant drugs, choice of drug versus alternative treatment, practical issues in prescribing and management, next-step treatment, relapse prevention, treatment of relapse and stopping treatment. Significant changes since the last guidelines were published in 2008 include the availability of new antidepressant treatment options, improved evidence supporting certain augmentation strategies (drug and non-drug), management of potential long-term side effects, updated guidance for prescribing in elderly and adolescent populations and updated guidance for optimal prescribing. Suggestions for future research priorities are also made.


抗抑郁症药物近年来发展迅速,其品种已超过20多种。目前,除三环类(tricyclic antidepressants,TCAs)作为经典抗抑郁症药仍保留TCAs这个名称外,国内外较多按作用机制划分命名,主要包括[9]:①5-HT再摄取抑制药(selective serotonin reuptake inhibitor,SSRIs),如氟西汀、帕罗西汀、舍曲林、氟伏沙明、西酞普兰和艾司西酞普兰;②选择性5-HT及NE再摄取抑制药(selective serotonin-norepinephrine reuptake inhibitors,SNRIs),如文拉法辛、度洛西汀;③NE及特异性5-HT能抗抑郁症药(noradrenergic and specific serotonergic antidepressant,NaSSA) ,如米氮平;④NE及DA再摄取抑制药(norepinephrine-dopamine reuptake inhibitors,NDRIs),如安非他酮;⑤5-HT2A受体拮抗药及5-HT再摄取抑制药(serotonin receptor antagonists reuptake inhibitor,SARIs),如曲唑酮、奈法唑酮;⑥单胺氧化酶抑制药(monoamine oxidase inhibitors,MAOIs),如苯乙肼、环苯丙胺及新一代可逆性MAOIs吗氯贝胺。除TCAs和MAOIs作为经典的第一代抗抑郁症药,上述药物多属于新一代抗抑郁症药。

如图可见,抑郁症可以由很多原因引起,比如家族病史,遗传因素,童年影音,家庭教育,成长环境,人生变故,身体因素,疾病,生产,药物酒精滥用,甚至环境因素,季节变换,水土不服等等等等。这些都可以归纳成为客观原因因,充分说明了抑郁症的客观存在性。比如,家庭病史可能会让你获得抑郁症的风险比别人高出10倍;敏感得性格让你更容易被伤害。这些都是真实存在的,而你对此无能为力。疾病,体弱,会让人缺乏能量导致暂时的焦虑和抑郁情绪。同时,长期的抑郁或者焦虑,会消耗身体里的化学物质和能量,甚至影响身体健康;反过来,又会加重抑郁病情。这也是为什么,抑郁症需要药物治疗的原因。可是,抑郁症却并不是我们从外界直接被动获得的,而是主观获得的。在此我更愿意把抑郁症比作一种习惯,一种自卑,自责,完美主义,自我怀疑等等不良应激反应的习惯。别误会,这种习惯并不是某个人由于自身素质问题而生出的三观问题,而恰恰是一种根据个人经历而产生的,非常原始自然“合理”的,符合“事实”的直觉/环境认知/自我总结。然而由于个体经历局限,认知局限,你所认为的”事实“经常会与实际事实,与或者别人眼中看到的你的事实,或者与对解决问题有利的事实之间,有相当的偏差。这也就是我所理解的人的局限。举个例子,一个从小被父亲当男孩奚落,母亲又常年在外留学的女孩子。她头发长过虱子,衣服常年脏兮兮,没有玩过洋娃娃,没有穿过裙子,没有在外面流过泪。青春期发育时,这个女孩子发育早个子又比当地男生高大,从小被人嘲笑。很长一段时间,她都非常羡慕干干净净穿着可爱颜色的衣服,梳子各色发型,个子娇小的女孩子,梨花带雨,楚楚可怜。后来,她变成了一个非常怕自己没有女人味的青年,总是害怕自己成为傻大个或者女汉子。再后来她交往了一个几年后由于异地劈腿,而让她之后独自痛苦了五年的初恋,初恋曾表示过喜爱铅笔腿类型的女孩而她不是。就像很多鸡汤文一样顺理成章的,女孩几个月不怎么吃饭狂运动变成了竹根女。很多年后,即使女孩最后变成一个高挑而明理的女人。可是明明处于偏低的正常体重, 却依然变态地执著于变瘦变小鸟依人而感觉自己可以获得更多的安全感。不在乎脸,不在乎妆容,不在乎身高不在乎一切,只是很容易因为胖瘦而没有自信。女孩脑中关于美丽和女人味的事实,和大多数人眼中的现实已经产生了差别。过度放大胖瘦在生活中的重要程度,因为这是她早年人生中所有不安全感的心理暗示来源。好了各位看官,这个例子就是本人系列。但我可以肯定,我这样的例子并不稀有,EATING DISORDER又是一个大写的大众病。说回来,通过以上例子,我想说的是,我们每个人都有自己的“牛角尖”,我们看到的事实,和真实的事实,多多少少是有差距的。我看到的镜子中的我自己,loser,恶心,没有女人味,这是我认识的自己,我认为的事实。而真实的事实可能又是另外一番景象。当各种事件发生时,我们会产生这种错误的,有偏差不必要的认知和结论;从而使自己反复确认错误的事实,陷入不必要的抑郁焦虑情绪中,迷失了解决问题的方向。所以在造成抑郁症的诸多原因之中,我认为,纠正这种错误认知的思维训练是最重要的。也是除了吃药以外,我们唯一可以调节的地方。其实这就是我们常说的认识世界,认识自己,坦然面对,修炼心性。而这个课题,每一个人都会遇到,如果抑郁这烂透的一段人生是你精神修炼的契机,我觉得未必不是一件好事。


Abstract BACKGROUND: Prefrontal Transcranial Magnetic Stimulation (TMS) therapy repeated daily over 4-6 weeks (20-30 sessions) is US Food and Drug Administration (FDA) approved for treating Major Depressive Disorder in adults who have not responded to prior antidepressant medications. In 2011, leading TMS clinical providers and researchers created the Clinical TMS Society (cTMSs) (www.clinicaltmssociety.org, Greenwich, CT, USA), incorporated in 2013. METHODS: This consensus review was written by cTMSs leaders, informed by membership polls, and approved by the governing board. It summarizes current evidence for the safety and efficacy of the use of TMS therapy for treating depression in routine clinical practice. Authors systematically reviewed the published TMS antidepressant therapy clinical trials. Studies were then assessed and graded on their strength of evidence using the Levels of Evidence framework published by the University of Oxford Centre for Evidence Based Medicine. The authors then summarize essentials for using TMS therapy in routine clinical practice settings derived from discussions and polls of cTMSs members. Finally, each summary clinical recommendation is presented with the substantiating peer-reviewed, published evidence supporting that recommendation. When the current published clinical trial evidence was insufficient or incomplete, expert opinion was included when sufficient consensus was available from experienced clinician users among the membership of the cTMSs, who were polled at the Annual Meetings in 2014 and 2015. CONCLUSIONS: Daily left prefrontal TMS has substantial evidence of efficacy and safety for treating the acute phase of depression in patients who are treatment resistant or intolerant. Following the clinical recommendations in this document should result in continued safe and effective use of this exciting new treatment modality. Copyright 脗漏 2016 The Authors. Published by Elsevier Inc. All rights reserved.能坐得久一点。站着的时候必须找东西靠着,有时候靠墙上,有时候靠着桌子,否则就会开始烦躁不安,感觉自己马上就会晕过去或者突然猝死一样。另外,我还特别怕吵闹,如果身边的人说话稍微大声一些,就会觉得很烦躁,很想逃离出去。感觉所有的噪声在拼命地往我脑子里钻。那段时间我非常抵触跟别人交谈,不必要的社交也都尽可能推掉,甚至上司请吃饭我都不想去。我开始越来越少说话,因为说多了会累,气接不上(这再次让我怀疑我肾虚)。因此,一整天,如非必要,我绝不开口说话。对于刚换了新工作的我来说,这等于是将自己与所有同事都隔绝开了。因此,每天一上班,我就觉得周围的气氛异常的压抑,大家都很陌生,即使我已经在那里上班超过两个月了,可是,依然无法跟身边的同事好好交流。上班成了一件非常痛苦的事情。
目前我国精神科医师常使用的抑郁症诊断分类系统包括世界卫生组织制定的《国际疾病分类》第十版(International Category of Disease, ICD-10)和美国的《疾病诊断与统计手册》第五版(Diagnostic and Statistical Manual of Mental Disorders, DSM-V),来帮助评估和诊断青少年抑郁症。研究还发现标准化的评估工具(量表和问卷等)可以帮助提高青少年抑郁症的识别率。成功用于诊断和评估青少年抑郁症的量表和问卷很多, 美国预防服务工作组(Preventive Services Task Force of United States, USPTF)推荐使用的青少年抑郁症筛查量表变包括贝克抑郁自评量表(Beck Depression Inventory,BDI),同时我国目前常用筛查量表还包括流调用抑郁量表(Center for Epidemiological Survey-Depression Scale, CES-D)、Kutcher青少年抑郁量表(Kutcher Adolescent Depression Scale,KADS)、儿童抑郁自评量表(Depression Self-Rating Scale for Children,DSRSC)、儿童抑郁量表(Children's Depression Inventory,CDI)、症状自评量表(Self-Reporting Inventory,SCL-90)等。
药物治疗的主要问题在于治疗之后仍然会有不少患者出现残留症状,大约有30%的病人在治疗结束之后仍然有一定程度的认知障碍,自杀几率以及复发几率。有研究发现在短期治疗下,35-50%的患者在药物治疗后康复,也有25-35%的患者在安慰剂的作用下同样康复,因此,可以推测出大约有2/3的抑郁症患者在治疗之后并没有完全康复,仍然有残留的症状。因为如此,就有很多研究探讨将最初的治疗效果最大化的方法,一个方法就是在使用抗抑郁药物的同时配套其他相关药物,比如有一个小型研究发现配合米氮平_百度百科 与氟西汀_百度百科,文拉法辛_百度百科 或安非他酮_百度百科 的效果比单一使用氟西汀_百度百科的效果要好。同时,也有研究发现在治疗初期就用大剂量的药物会有较好的反应效果,但是,这个效果并不是那么显著并且大剂量的药物会导致更严重的停药反应。另外,也有不少研究发现在药物治疗的基础上配合认知行为疗法CBT的话效果更为出众。
×